GSK2402968
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GSK2402968, covering 2014-08-25 to 2019-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy [Phase 3]